Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.
Season’s greetings from BIOMEDICA CRO team!
DEAR PARTNERS, As the holiday season approac...
Caucasian and African-American woman biospecimens comparing in discovery of new biomarkers for rheumatoid arthritis
Caucasian donors of biospecimens role in disc...
New protein variant underlies the ability of gastric cancers to resist chemotherapy
A new protein variant underlies the ...
How to choose a company for human biospecimen collection?
Science is moving forward and the wo...
Red blood cell distribution width as a biomarker for COVID-19
Biomarkers of COVID-19: red blood ce...
Breaking down fungal biofilm defenses provides potential path to treating sticky infections
Breaking down fungal biofilm defenses provide...
Whole genome sequencing could benefit patients with cancer
Whole genome sequencing could benefit patient...
First human vaccine trial to prevent triple negative breast cancer begins
Vaccine to prevent breast cancer Cleveland C...
